Global Microfluidics Market to 2022 - By Material (Ceramics, Polymers), Components (Microfluidic Chips, Pumps, Needles), Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - ResearchAndMarkets.com

September 25, 2018

DUBLIN--(BUSINESS WIRE)--Sep 25, 2018--The “Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022” report has been added to ResearchAndMarkets.com’s offering.

The market for microfluidic devices all over the world was worth US$ 3.6 Billion in 2017, and is poised for a double digit growth during the forecasted period (2017-2022).

The new report also focuses on microfluidics market by material, such as ceramics, polymers, glass, and silicon; by components, such as microfluidic chips, pumps, and needles; by application, and territory. The In-Vitro diagnostics segment commands the largest share of the global microfluidics applications market.

The large share of this segment is attributed to the increasing adoption of microfluidics for Point-of-Care & Clinical and Veterinary diagnostics application by major diagnostic companies, such as Roche, Becton Dickinson and Company, Abbott, and Cepheid amongst others. Similarly, in microfluidics by components segment, microfluidic chips accounted for the largest share. This large share is attributed to increasing usage of these chips in IVD application.

Based on material, in 2017, ceramics contributed the major share in microfluidics market. This high share is attributed to high chemical resistivity, versatility, and strength offered by ceramics in manufacturing of microfluidics devices.

Asia Pacific is poised to witness a lucrative growth in the coming years. This is attributed to the increasing mergers and acquisitions, and technological advancements in emerging countries. However, North America accounted for the largest share in 2017. The increasing adoption of microfluidics technology and the incessant launches of new products in the North American region are driving the market growth.

In addition, this study also covers latest trends and developments capturing the market since last few years. The report also includes the regulatory scenario in various countries across the globe.

The key vendors dominating the market space are Fluidigm Corp., Roche, Agilent Technologies Inc., Illumina, Inc., Shimadzu, Abbott, etc. Finally, the report covers strengths and weaknesses, and recent developments on the competitive front. Thus, it provides a comprehensive analysis of the microfluidics technology, which will enable investors and debut makers to design relevant business strategies to target the billion dollar market.

Drivers & Challenges


Rising Incidence of Chronic Diseases Increasing Demand of Point of Care Diagnostics Rising Application in Life Sciences Research Benefits of Miniaturization of Chip


Manufacturing Difficulties & High Cost of Lab-on Chips Instruments Ambiguous Regulatory Framework Lack of Awareness in Emerging Markets

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. Microfluidics - An Introduction

4. Microfluidics Market Overview

5. Drivers & Challenges

6. Market Segmentation

7. Regulatory Scenario

8. Trends & Developments

9. Competitive Assessment

Fluidigm Corporation F. Hoffmann-La Roche Ltd. Bio-Rad Laboratories, Inc. Thermo Fisher Scientific, Inc. Agilent Technologies, Inc. Perkin Elmer, Inc. Illumina, Inc. Shimadzu Corporation Danaher Corporation Abbott

For more information about this report visit https://www.researchandmarkets.com/research/259v5d/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180925005559/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Delivery,Drug Discovery,In Vitro Diagnostics,Infusions and Injectables ,Needles and Syringes



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/25/2018 06:44 AM/DISC: 09/25/2018 06:44 AM


Update hourly